Skip to content

Effects of differ sites repetitive transcranial magnetic stimulation on lower limb motor function and gait balance in stroke patients with hemiplegia

Effects of differ sites repetitive transcranial magnetic stimulation on lower limb motor function and gait balance in stroke patients with hemiplegia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069274
Enrollment
Unknown
Registered
2023-03-11
Start date
2023-03-06
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lower extremity dsyfunction of stroke

Interventions

M1 sites stimulation group:Routine rehabilitation therapy + M1 repeated transcranial magnetic stimulation therapy
cerebellar sites stimulation:Routine rehabilitation therapy + cerebellar repeated transcranial magnetic stimulation therapy
control group:Routine rehabilitation therapy +sham stimulation

Sponsors

Yuebei People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. In accordance with the diagnostic criteria of ''stroke'' in the Chinese Classification of Cerebrovascular Diseases 2015, the diagnosis was confirmed by head MRI or CT examination; 2. The course of the disease was more than 2 weeks, and the vital signs were stable; 3. First stroke or previous lacunar infarction without sequelae; 4. Aged 18-80 years; 5. Brunnstrom stage >=? of the affected lower extremity, no severe lower extremity spasm, modified Ashworth scale score =21 points, can cooperate with treatment and evaluation; 8. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Women of childbearing age who wear pacemakers, have metal implants in the brain or other metal implants in the body, or have skull defects, epilepsy patients, pregnancy, lactation, or have not taken reliable contraceptive measures; 2. Patients with serious systemic diseases cannot participate in the study: patients with severe respiratory, heart, liver, kidney, endocrine, hematopoietic and other diseases, such as congestive heart failure, arrhythmia, and failure to control hypertension; 3. Significant limb disability or other diseases affecting lower limb movement: severe lower limb infection, contracture, joint surgery, amputation, fracture, rheumatism or rheumatoid arthritis; 4. Those with serious speech, vision, hearing disorders (such as deaf-mutes) or mental disorders that affect the examination and treatment; 5. Patients recently enrolled in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Lower Limb Fugl-Meyer Assessment Scale;Berg Balance Scale, BBS;Lower limb peak torque to body weight ratio;Balance Test System Scale;Three-dimensional gait analysis;

Secondary

MeasureTime frame
Modified Brathel Scale (MBI);

Countries

China

Contacts

Public ContactLai Feng

Department of Rehabilitation Medicine, YueBei People's Hospital

laifeng190016@163.com+86 188 2634 7765

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026